| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |